Otolaryngologia polska = The Polish otolaryngology · 2016
Assesment effectiveness of treatment Eustachian tube dysfunction using pneumatic inhaler AMSA.
Сравнительное исследованиеСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zając-Ratajczak Iwona, Szkiełkowska Agata, Wilhelmsen Karina
Аннотация
INTRODUCTION: Upper respiratory tract infections are common childhood diseases. Children are more susceptible to middle ear infections because their Eustachian tube is short, straight and wide. As a consequence of these inflammatory changes while impaired patency of the Eustachian tube often arises conductive hearing.
OBJECTIVE: The aim of this study was to Assessment effectiveness of treatment Eustachian tube dysfunction using inhaler AMSA.
MATERIAL AND METHODS: The study group comprised 30 patients. Same was in the control group. All patients reported conductive hearing loss. Test group was treated as an inhaler AMSA. The control group was treated pharmacologically. Patients were examined with the use of pure-tone audiometry, and impedance at baseline, after one week and four weeks.
RESULTS: Statistical analysis showed improvement in the studied parameters in patients treated with inhaler AMSA in a much shorter time than patients treated with pharmacotherapy.
OBJECTIVE: The aim of this study was to Assessment effectiveness of treatment Eustachian tube dysfunction using inhaler AMSA.
MATERIAL AND METHODS: The study group comprised 30 patients. Same was in the control group. All patients reported conductive hearing loss. Test group was treated as an inhaler AMSA. The control group was treated pharmacologically. Patients were examined with the use of pure-tone audiometry, and impedance at baseline, after one week and four weeks.
RESULTS: Statistical analysis showed improvement in the studied parameters in patients treated with inhaler AMSA in a much shorter time than patients treated with pharmacotherapy.